David P Bonita insider trades: ImageneBio (IMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 6 more companies
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | IMA | ↑ Buy | 83,611 | $29.90 | $2.5M | Indirect | Jul 30, 2025 (5d) |
| May 22, 2023 | PRLD | ↑ Buy | 869,565 | $5.75 | $5.0M | Indirect | May 24, 2023 (2d) |
| Nov 25, 2022 | TCDA | ↓ Sell | 10,280,947 | $0.21 | $2.2M | Indirect | Nov 25, 2022 (0d) |
| Sep 19, 2022 | THRD | ↑ Buy | 300,000 | $17.00 | $5.1M | Indirect | Sep 21, 2022 (2d) |
| Jun 24, 2022 | IKNA | ↑ Buy | 252,225 | $4.47 | $1.1M | Indirect | Jun 24, 2022 (0d) |
| Sep 7, 2021 | RPTX | ↓ Sell10b5-1 | 8,084 | $33.99 | $275K | Indirect | Sep 8, 2021 (1d) |
| Sep 2, 2021 | RPTX | ↓ Sell10b5-1 | 37,864 | $34.08 | $1.3M | Indirect | Sep 2, 2021 (0d) |
| Aug 30, 2021 | RPTX | ↓ Sell10b5-1 | 18,073 | $34.07 | $616K | Indirect | Aug 30, 2021 (0d) |
| Aug 25, 2021 | RPTX | ↓ Sell10b5-1 | 18,215 | $34.17 | $622K | Indirect | Aug 25, 2021 (0d) |
| Aug 18, 2021 | RPTX | ↓ Sell10b5-1 | 20,328 | $34.10 | $693K | Indirect | Aug 25, 2021 (7d) |
| Aug 18, 2021 | RPTX | ↓ Sell10b5-1 | 20,328 | $34.10 | $693K | Indirect | Aug 19, 2021 (1d) |
| Jul 19, 2021 | AFIB | ↑ Buy | 1,071,428 | $14.00 | $15.0M | Indirect | Jul 21, 2021 (2d) |
| Jul 16, 2021 | IMRA | ↑ Buy | 1,666,666 | $6.00 | $10.0M | Indirect | Jul 16, 2021 (0d) |
| Mar 30, 2021 | IKNA | ↑ Buy | 423,400 | $16.00 | $6.8M | Indirect | Apr 1, 2021 (2d) |
| Sep 25, 2020 | PRLD | ↑ Buy | 1,236,800 | $19.00 | $23.5M | Indirect | Sep 30, 2020 (5d) |
| Aug 10, 2020 | AFIB | ↑ Buy | 415,000 | $18.00 | $7.5M | Indirect | Aug 12, 2020 (2d) |
| Jun 23, 2020 | RPTX | ↑ Buy | 774,200 | $20.00 | $15.5M | Indirect | Jun 25, 2020 (2d) |
| Mar 12, 2020 | IMRA | ↑ Buy | 937,500 | $16.00 | $15.0M | By OrbiMed Private Investments VII, LP | Mar 16, 2020 (4d) |
| Dec 11, 2019 | TCDA | ↓ Sell | 1,500,000 | $40.00 | $60.0M | By OrbiMed Private Investments V, LP | Dec 12, 2019 (1d) |
| Apr 3, 2019 | TCDA | ↑ Buy | 225,000 | $36.00 | $8.1M | By OrbiMed Private Investments V, LP | Apr 5, 2019 (2d) |
| Oct 19, 2018 | SIBN | ↑ Buy | 200,000 | $15.00 | $3.0M | By OrbiMed Private Investments V, LP | Oct 19, 2018 (0d) |
| Jul 2, 2018 | TCDA | ↑ Buy | 368,421 | $19.00 | $7.0M | By OrbiMed Private Investments V, LP | Jul 2, 2018 (0d) |
| Dec 8, 2017 | LOXO | ↓ Sell | 250,000 | $82.50 | $20.6M | Indirect | Dec 12, 2017 (4d) |
| Nov 22, 2017 | LOXO | ↓ Sell | 267,000 | $75.00 | $20.0M | Indirect | Nov 27, 2017 (5d) |
| Nov 16, 2017 | LOXO | ↓ Sell | 270,000 | $74.26 | $20.1M | Indirect | Nov 20, 2017 (4d) |
| Jan 18, 2017 | VRAY | ↑ Buy | 330,577 | $3.00 | $992K | Indirect | Jan 20, 2017 (2d) |
| Aug 22, 2016 | VRAY | ↑ Buy | 1,138,074 | $2.95 | $3.4M | Indirect | Aug 24, 2016 (2d) |
| Aug 10, 2016 | LOXO | ↓ Sell | 447,857 | $26.96 | $12.1M | Indirect | Aug 12, 2016 (2d) |
| Aug 6, 2014 | LOXO | ↑ Buy | 275,385 | $13.00 | $3.6M | Indirect | Aug 6, 2014 (0d) |
| May 23, 2013 | AMBI | ↑ Buy | 33,800 | $6.91 | $234K | Indirect | May 24, 2013 (1d) |
| May 21, 2013 | AMBI | ↑ Buy | 680,471 | $7.97 | $5.4M | Indirect | May 22, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMA insiders
Open-market trades in the last 12 months
About David P Bonita's insider trades
David P Bonita is an insider at ImageneBio (IMA). Since May 21, 2013, David has reported 19 open-market purchases worth $138.6M and 12 sales worth $139.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (3% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (43 filings), conversions (10 filings), other transactions (6 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.